Ali Awol Mekonnen, Adam Haileyesus, Hailu Daniel, Howe Rawleigh, Abula Teferra, Coenen Marieke J H
Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Department of Pediatrics and Child Health, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Appl Clin Genet. 2023 Aug 2;16:131-137. doi: 10.2147/TACG.S404695. eCollection 2023.
L-asparaginase is a vital component for the treatment of childhood acute lymphoblastic leukemia (ALL); however, hypersensitivity reactions and hepatotoxicity hinder its anti-neoplastic efficacy. Previous reports indicated that genetic variants in , and genes might be associated with hypersensitivity reactions and with liver function.
In this study, it was investigated whether this association also exists in a pediatric ALL cohort from Ethiopia.
Three variants rs4958351, rs73062673, and rs6021191 were genotyped in a cohort of 160 patients. Association analysis to investigate the association with hypersensitivity reactions was performed using logistic regression analyses. Besides these variants, a variant in (rs738409) was genotyped to assess the association with liver function.
Genotype frequencies of rs4958351, rs73062673, and rs6021191 were higher/lower than previously reported. One hundred and forty-four patients were included in the association analysis of which, 18 (12.5%) developed L-ASP hypersensitivity. Though the frequency of hypersensitivity was higher in patients that carried the risk alleles of the three investigated genes, no statistically significant differences were observed. Association analysis between rs738409 and liver function could not be investigated due to a lack of clinical information.
In conclusion, none of the tested genes did predict L-asparaginase hypersensitivity in an Ethiopian pediatric ALL patients.
L-天冬酰胺酶是治疗儿童急性淋巴细胞白血病(ALL)的重要组成部分;然而,过敏反应和肝毒性阻碍了其抗肿瘤疗效。先前的报告表明, 、 和 基因的遗传变异可能与过敏反应有关,而 基因的变异与肝功能有关。
本研究调查了这种关联在埃塞俄比亚的儿科ALL队列中是否也存在。
对160例患者的队列进行了3个变异体rs4958351、rs73062673和rs6021191的基因分型。使用逻辑回归分析进行关联分析以研究与过敏反应的关联。除了这些变异体,还对 基因中的一个变异体(rs738409)进行了基因分型,以评估与肝功能的关联。
rs4958351、rs73062673和rs6021191的基因型频率高于/低于先前报道。144例患者纳入关联分析,其中18例(12.5%)发生L-ASP过敏。虽然携带3个研究基因风险等位基因的患者过敏频率较高,但未观察到统计学上的显著差异。由于缺乏临床信息,无法研究rs738409与肝功能之间的关联。
总之,在埃塞俄比亚儿科ALL患者中,所检测的基因均未预测L-天冬酰胺酶过敏。